Interleukin 21 (IL21) (C-Term) Peptide
Quick Overview for Interleukin 21 (IL21) (C-Term) Peptide (ABIN8103359)
Target
Origin
Source
Application
-
-
Protein Region
- C-Term
-
Purpose
- IL21 Peptide - C-terminal region
-
Sequence
- ERIINVSIKK LKRKPPSTNA GRRQKHRLTC PSCDSYEKKP PKEFLERFKS
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
This is a synthetic peptide designed for use in combination with anti-IL21 Antibody (ARP60746_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- IL-21 (IL21) (Interleukin 21 (IL21))
-
Background
-
Background Information: This gene encodes a member of the common-gamma chain family of cytokines with immunoregulatory activity. The encoded protein plays a role in both the innate and adaptive immune responses by inducing the differentiation, proliferation and activity of multiple target cells including macrophages, natural killer cells, B cells and cytotoxic T cells. Dysregulation of this gene plays a role in multiple immune-mediated diseases including lupus, psoriasis and chronic inflammatory diseases. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene.
Alternative Symbols: IL-21, Za11
-
Molecular Weight
- 16kDa
-
Gene ID
- 59067
-
NCBI Accession
- NP_001193935
Target
-
